We are pleased to announce that Evidently has joined the portfolio, closing a US$15 million Series A round led by DN Capital with participation from FRAMEWORK, Clear Ventures, Fellows Fund and existing investors.

‍

Based in Palo Alto, Evidently is a pioneering Cognitive AI platform provider, offering revolutionary solutions that enable healthcare providers to access and utilize clinical data effectively. Their platform empowers clinicians with streamlined workflows and comprehensive data insights, enhancing the quality of care, reducing the administrative burden, and optimizing revenue recognition. 

‍

The rapid growth of healthcare data presents challenges such as managing structured and unstructured information, and deriving actionable insights. Clinicians often face information overload with insufficient time to review files, which hinders decision-making, threatens patient lives and provider wellbeing, and causes coding errors and financial losses. 

Evidently acts as an AI resident, intelligently synthesizing information from disparate sources including external health records and faxes, and delivers concise, actionable summaries alongside real-time decision support. Acting as a coding coach for risk adjusters and complexity-based coding, and a research assistant for clinical trials, the cognitive AI engine empowers clinicians to make more informed decisions and deliver exceptional care, drive institutional quality and revenue goals, and spend less time on tasks leading to burnout. 

Evidently’s platform is already driving exceptional financial and efficiency gains at leading health systems across the US, reducing transplant referral chart prep time by over 90%, improving client's Case Mix Index accuracy while reducing queries, and enabling a post-acute care ACO to achieve a 1.4 increase in Risk Adjustment Factor through harmonized data aggregation. 

We are extremely excited to be partnering with Feng, Kalie, and the rest of the Evidently team, who have built a best in class platform that makes data instantly actionable for everyone across the care continuum. The funding will enable Evidently to meet the rapidly growing demand for its ‘EvidentlyOne’ product while advancing new solutions for population health and clinical research.

‍

Visit Evidently website for more: https://evidently.com